Evaluate, you say "it could be" and "its feasible" to have royalty payments from the hospitals and level 3 distributors. I don't think thats happening and can't find anything in the Qs that indicate a royalty structure in addition to the basic equipment lease.
The most recent 10K (Dec 31 2019) includes:
The Company has the following three revenue streams:
1) Product sales (equipment and/or fluid solutions): Contracts for product sales consist of invoices specify the transaction price. The only performance commitment is the provision of products and the transaction price is allocated to the products specified on the invoice. The Company recognizes revenue from the sale of products when the performance obligation is satisfied by transferring control of the product to a customer.
2) Licensing: The Company licenses a contract-based use of the Company’s US EPA Product Registration, returning revenue in licensing fees and/or royalties from minimum or actual fluid sales. The Contract specifies the term, fees and or royalty. Performance obligations include the provision of a sub registration to use the US EPA Product Registration and or the provision of a license to use the product for a period of time. The Company allocates the transaction price based on the relative standalone selling price of each performance obligation. The Company’s licenses provide a right to use and create performance obligations satisfied at a point in time. The Company recognizes revenue from licenses when the performance obligation is satisfied through the transfer of the license. For licenses that include royalties the Company will recognize royalty revenue as the underlying sales or usages occur, as long as this approach does not result in the acceleration of revenue ahead of the entity’s performance.
3) Equipment leases: Contracts for equipment leases are systems service agreements, usually 3-year contracts for the provision of the Company’s equipment and service of such, under contract to customers, with renewable terms. The performance obligation consists of the provision of with leased equipment The Company recognizes revenue from the leasing of equipment as the entity provides the equipment and the customer simultaneously receives and consumes the benefits through the use of the equipment. This revenue generating activity would meet the criteria for a performance obligation satisfied over time. As a result, the Company recognizes revenue over time by using the output method, as the Company can measure progress of the performance obligation using the time elapsed under each obligation.
https://www.businesswire.com/news/home/20200318005687/en/PCT-LTD-Receives-Large-Purchase-Order-for-Recurring-Sales-of-Fluids-for-Non-Medical-Use-and-Explains-Current-Revenue-Streams includes: PCT LTD Receives Large Purchase Order for Recurring Sales of Fluids for Non-Medical Use and Explains Current Revenue Streams March 18, 2020 02:52 PM Eastern Daylight Time LITTLE RIVER, S.C.--(BUSINESS WIRE)--PCT LTD (OTC Pink: PCTL) ("PCTL") is pleased to announce they have obtained a large pre-paid order from an existing sub-registrant in the Midwestern United States for 10,000 gallons of a specific fluid solution, with regular, recurring orders expected to follow. PCT LTD CEO, Gary Grieco commented, “Our customer is ramping up their business to meet new contracts and we’re here to help them meet the growing demand.”
PCT LTD has been attracting increased attention as of late due to their Annihilyzer® Infection Control System which is currently installed in 9 US hospitals and 1 in the United Kingdom. However, its flagship Annihilyzer® product is far from the company’s only source of revenue. PCT LTD also generates revenue from the sale of equipment, the sale of fluids, in addition to licensing and royalty fees from its sub-registrants, distributors, and other customers.
With the company’s existing US EPA registration, PCT LTD has licensed a select number of companies as sub-registrants. Using PCT’s US EPA registration, the company licenses the use or sale of its proprietary products, including fluids such as Hydrolyte® and Hydrolyte® generators. Royalty agreements are also part of PCT’s revenue model and are often, though not exclusively, negotiated on a per gallon basis with sub-registrants.
Having multiple revenue streams is an important focus of the company’s business model, explains PCT Corp. President Bill Prince. “We’ve been active in our efforts to expand our network of quality sub-registrants and distributors in order to facilitate strategic growth. With multiple revenue streams, we’re able to achieve these goals more efficiently.”
PCT LTD currently has three active sub-registrants in two US states and one in Puerto Rico. The company currently has distributors in 3 US states. Collaborative and other agreements are in place with other complimentary business “partners.” Additional sales and installations are expected to be announced in coming weeks as the company expands its operations and continues to build on its current growth trajectory.
In a recent interview with the Stock Day Media Podcast, CEO Gary Grieco discussed the effectiveness of the product, competitive advantages over other cleaning solutions, and provided an update on the company’s current growth. Highlights include numerous international inquiries, transitioning to operating profit, and record revenue flow in the first quarter of 2020.
“One of the big problems with any small company is profitability. I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter.” – Gary Grieco, CEO.
At the conclusion of the episode, Grieco and host Everett Jolly agreed to have Gary back on the show in the coming weeks to provide an additional update.
To hear the complete interview with Stock Day host Everett Jolly follow the link to the podcast here: PCT LTD Discusses Their Unique Annihilyzer Disinfecting System and Impact of the Coronavirus. This podcast is also available on The Stock Day Media Website in addition to iTunes and other audio platforms.